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Abstract 64 
 65 
Background and Purpose 66 
The volume of estimated ischemic core using computed tomography perfusion (CTP) imaging 67 
can identify ischemic stroke patients who are likely to benefit from reperfusion, particularly 68 
beyond standard time windows. We assessed the accuracy of pre-treatment CTP estimated 69 
ischemic core in patients with successful endovascular reperfusion.  70 
 71 
Methods 72 
Patients from the HERMES and EXTEND-IA TNK databases who had pre-treatment CTP, 73 
>50% angiographic reperfusion, and follow-up MRI at 24h were included. Ischemic core 74 
volume on baseline CTP data was estimated using relative cerebral blood flow <30% 75 
(RAPID, iSchemaView). Follow-up diffusion MRI was registered to CTP and the diffusion 76 
lesion was outlined using a semi-automated algorithm. Volumetric and spatial agreement 77 
(using Dice similarity co-efficient, Average Hausdorff Distance and precision) were assessed 78 
and expert visual assessment of quality performed.  79 
 80 
Results 81 
In 120 patients, median CTP estimated ischemic core volume was 7.8(IQR 1.8-19.9)ml and 82 
median diffusion lesion volume at 24h was 30.8(IQR 14.9-67.6)ml. Median volumetric 83 
difference was 4.4(IQR 1.2-12.0)ml. Dice similarity coefficient was low (median 0.24, IQR 84 
0.15-0.37). The median precision (positive predictive value) of 0.68(IQR 0.40-0.88) and 85 
Average Hausdorff Distance (median 3.1, IQR 1.8-5.7mm) indicated reasonable spatial 86 
agreement for regions estimated as ischemic core at baseline. Overestimation of total 87 
ischemic core volume by CTP was uncommon. Expert visual review revealed overestimation 88 
predominantly in white-matter regions. 89 
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Conclusion 90 
CTP estimated ischemic core volumes were substantially smaller than follow-up DWI lesions 91 
at 24h despite endovascular reperfusion within 2h of imaging. This may be partly due to 92 
infarct growth. Volumetric CTP core overestimation was uncommon and not related to 93 
imaging-to-reperfusion time. Core overestimation in white-matter should be a focus of future 94 
efforts to improve CTP accuracy.   95 
 96 
97 
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Introduction 98 
Early reperfusion in acute ischemic stroke is the key to reducing disability.1 Multiple 99 
randomized trials2-8 have shown that endovascular thrombectomy reduces disability versus 100 
standard care within 6h of stroke onset. The DAWN9 and DEFUSE310 trials have successfully 101 
used imaging selection based on CTP or MRI processed with RAPID software 102 
(iSchemaView, Mountain View, CA, USA) to identify patients >6h after last known well time 103 
who benefit from reperfusion. Although analyses of 0-6h data have not shown an interaction 104 
between CTP core volume and the treatment effect of endovascular thrombectomy, CTP may 105 
have diagnostic and prognostic value for patients within 6h.11-13 Several studies assessing 106 
contemporaneous CTP and diffusion-weighted MRI (MR-DWI) have shown reasonable 107 
agreement in estimates of the extent of permanently injured tissue.14,15 However, CTP results 108 
have varied between post-processing techniques and thresholds applied by different 109 
software.11,16,17  110 
 111 
Although CTP is fast and easily accessible in the acute setting of ischemic stroke, it is 112 
recognized that cerebral blood flow (CBF) map segmentations tend to include false-positive 113 
regions in areas of hypodense white-matter (leukoaraiosis).18 CBF is physiologically lower in 114 
white versus grey-matter and further reduced in regions of leukoaraiosis.18 Given DAWN and 115 
DEFUSE3 results, standardized CTP post-processing software with validated thresholds is 116 
likely to be increasingly used clinically to select patients for reperfusion therapies beyond 117 
standard therapeutic time windows. A crucial question, therefore, is how reliable CTP 118 
estimates of irreversible injury are in the current endovascular paradigm of fast reperfusion.19 119 
 120 
We aimed to assess the volumetric and spatial agreement of estimated ischemic core on CTP 121 
with follow-up infarct on DWI. We hypothesized that CTP data, when appropriately 122 
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thresholded, could provide a reliable volumetric and spatial estimation of the follow-up 123 
infarct.  124 
Materials and methods 125 
Patient selection 126 
This study pooled individual patient data from seven randomized trials of endovascular 127 
thrombectomy (HERMES collaboration)2-8,20,21 and from the EXTEND-IA TNK trial.22 The 128 
EXTEND-IA TNK trial tested the safety and efficacy of intravenous tenecteplase versus 129 
alteplase prior to thrombectomy in ischemic stroke patients. The data that support the findings 130 
of this study are available from the corresponding author upon reasonable request. The degree 131 
of reperfusion post-thrombectomy was assessed on the final angiogram using the modified 132 
Treatment In Cerebral Infarction (mTICI) score. To best estimate the accuracy of baseline 133 
CTP after endovascular reperfusion, only patients who had substantial reperfusion (defined as 134 
mTICI 2b/3, i.e. reperfusion of >50% of the affected territory) were included in this analysis. 135 
Sensitivity analysis was performed in patients achieving mTICI 2c/3, i.e. reperfusion of all 136 
but a few distal cortical branches.23 Patients were required to have technically adequate 137 
baseline CTP and 24h DWI follow-up. The following patient characteristics were noted: age, 138 
sex, baseline NIHSS, baseline estimated ischemic core volume, hypertension, atrial 139 
fibrillation, diabetes mellitus, blood glucose, and smoking. Ethics approval was obtained from 140 
the local institutional review boards and written informed consent was obtained from patients 141 
or legal representatives. 142 
 143 
CTP post-processing 144 
CTP data were post-processed using RAPID (v4.5, Research Mode) and visually checked for 145 
artefacts. Ischemic core was defined as relative CBF<30% of normal brain (see online 146 
supplement http://stroke.ahajournals.org). 147 
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 148 
Data co-registration and segmentation 149 
The 24h follow-up DWI was coregistered to the baseline CTP. Hemorrhagic transformation 150 
(HT) was graded using the ECASS classification.24 Sensitivity analysis was performed 151 
excluding patients with hemorrhagic infarction type 2 and parenchymal hematoma.  152 
 153 
Assessment of volumetric and spatial agreement 154 
The volumetric difference between CTP and DWI ischemic core was defined as DWI volume 155 
minus CTP core volume. Magnitude of volumetric difference is also reported. CTP and DWI 156 
lesion overlap was calculated using FSLMaths (see online supplement 157 
http://stroke.ahajournals.org) and spatial agreement assessed using FSLStats and the 158 
EvaluateSegmentation tool.25 The Dice similarity coefficient was calculated to assess spatial 159 
agreement between CTP and DWI lesions. The positive predictive value (PPV) was used to 160 
assess the proportion of the initial CTP lesion that fell within the 24h diffusion lesion. Unlike 161 
Dice, PPV is not diminished by regions of infarction at 24h that fall outside the baseline CTP 162 
lesion, potentially reflecting infarct growth. We also used the Average Hausdorff Distance 163 
(AVD, the average of all minimum distances between the two segmentations) to quantify 164 
spatial agreement.25 Patients with 0ml ischemic core within the CTP coverage were included 165 
in volumetric analyses but excluded from spatial analyses as the outcome measures were not 166 
calculable.  167 
 168 
Regions of apparent CTP misclassification were visually assessed for topography (white 169 
versus grey-matter) and co-registration accuracy. The quantity of CTP lesion outside the 170 
follow-up infarct (defined as core volume overestimation) was quantitatively trichotomized as 171 
0-5ml, 5-10ml and >10ml. To quantitatively assess the impact of co-registration inaccuracies 172 
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on the outcome metrics, we segmented the ventricles of 13 HERMES patients and 56 173 
EXTEND-IA TNK patients (see online supplement http://stroke.ahajournals.org).  174 
 175 
Statistical analysis 176 
Statistical analysis was performed using SPSS (v24 IBM, Armonk, NY). Spearman 177 
Correlation Coefficient () was calculated for correlations between variables.  178 
 179 
Results 180 
One-hundred and twenty patients with baseline CTP and 24h MRI met inclusion criteria for 181 
this study. Follow-up imaging was performed at median 24.4h(IQR 22.0-27.8h). In 182 
HERMES, 523/738(71%) patients assigned to thrombectomy had substantial reperfusion,7,8,21 183 
and 61 had requisite imaging. On 20/March/2017, 130 stroke patients were included in the 184 
EXTEND-IA TNK trial, 76/130(58%) achieved substantial angiographic reperfusion and 59 185 
had requisite imaging. Overall, 118/120(98%) patients were treated <6h after symptom onset. 186 
Only two HERMES patients had stroke onset-to-treatment time >6h (8.2 and 8.8h). Patient 187 
characteristics are detailed in Table 1. 188 
 189 
Volumetric and spatial agreement analysis 190 
For the 19/120(16%) patients without detectable ischemic core within the CTP coverage, the 191 
median follow-up infarct volume (and thus median volumetric difference between baseline 192 
CTP ischemic core and follow-up infarct volume) was 13.1(IQR 7.9-21.3)ml. In the 193 
remaining 101(84%) patients, the median estimated baseline ischemic core lesion volume of 194 
7.8ml increased to 30.8ml on 24h DWI with a median difference of 25.4ml (Table 1). Overall, 195 
the median volumetric difference was 25.4(IQR 10.0-63.7)ml. In sensitivity analysis 196 
excluding patients with HT, the median volume difference was 20.9ml. Median volume 197 
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difference in the 20 patients with HT was 69.1(IQR 24.3-142.2)ml. Increased absolute 198 
volumetric difference was associated with increased estimated baseline ischemic core volume 199 
(ρ=0.36, p<0.0001, Figure 1).  200 
 201 
The median Dice was 0.24(IQR 0.15-0.37). The median overlap of baseline and 24h lesions 202 
was 4.4(IQR 1.2-12.0)ml. However, the median PPV was 0.68(IQR 0.40-0.88). The median 203 
AVD was 3.1(IQR 1.8-5.7)mm. Data are summarized in Table 2 and results of sensitivity 204 
analysis in patients with almost complete reperfusion were similar (supplementary Table I, 205 
http://stroke.ahajournals.org). As a measure of the influence of registration accuracy on the 206 
maximum achievable spatial agreement, manual segmentation of ventricles had median Dice 207 
0.79(IQR 0.71-0.84), median PPV 0.81(0.72-0.87), and median AVD 0.4(0.2-0.6)mm. 208 
              209 
Ischemic core overestimation and expert visual qualitative assessment 210 
There were 6/120(5%) patients with CTP estimated ischemic core volume larger than the 24h 211 
DWI lesion volume, median volumetric difference 4.5(range 0.6-18.9)ml. Visual analysis of 212 
lesion spatial overlap indicated that 91/120(76%) patients had some region of baseline core 213 
outside the 24h infarct. Apparent core overestimation was 0.1-5.0ml in 63/120(53%) patients 214 
(median 1.1, IQR 0.3-3.1ml) and located in white-matter in 46/63 patients. There were 21/120 215 
(18%) patients with 5-10ml core overestimation (median 6.9, IQR 5.9-8.1ml), located in 216 
white-matter in 18/21 patients and 17/120(14%) patients had >10ml core overestimation 217 
(median 18.3, IQR 14.3-25.5ml), 14/17 located predominantly in white-matter. Nine patients 218 
(9%) showed regions of baseline ischemic core that were not included in the follow-up infarct 219 
most likely due to poor registration, as judged by the same anatomical structures being 220 
included in both lesions. While misregistration may also have contributed to ischemic core 221 
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overestimation in other patients, the overrepresentation of white-matter regions was 222 
substantial (Figure 2). 223 
 224 
Effect of time from imaging to reperfusion 225 
Median time between baseline imaging and reperfusion was 114(IQR 82-159) min. CTP 226 
spatial accuracy was not associated with imaging-to-reperfusion time using Dice 227 
(ρ=-0.08, p=0.41), AVD (ρ=0.08; p=0.43) or PPV (ρ=-0.02, p=0.84). Longer imaging-to-228 
reperfusion time, however, was associated with an increased volumetric difference between 229 
baseline ischemic core and 24h follow-up infarct. (ρ=0.2, p=0.05, Figure 3). In spatial 230 
analysis, there was no significant difference in core overestimation between the 0-90min, 90-231 
180min or >180min imaging-to-reperfusion time subgroups (Figure 4). The median core 232 
overestimation in spatial analysis was 2.2(IQR 0.6-7.4)ml for 0-90min, 2.9(IQR 0.6-6.8)ml 233 
for 90-180min, and 7.4(IQR 3.5-17.8)ml for >180min subgroups (p=0.03 for 0-90 vs. 234 
>180min and p=0.03 for 90-180 vs. >180min). The median volume difference was 25.4(IQR 235 
6.0-35.7)ml for 0-90min, 22.8(IQR 11.2-51.3)ml for 90-180min, and 60.0(IQR 21.1-91.7)ml 236 
for >180min subgroups. 237 
 238 
Discussion 239 
This study comparing baseline estimated ischemic core using a CTP-CBF threshold <30% of 240 
normal brain has demonstrated moderate spatial and volumetric agreement with follow-up 241 
DWI lesion. Volumetric overestimation of the ischemic core was rare. A degree of false 242 
positive core segmentation was detected in 76% of patients using spatial analysis, but was 243 
>10ml in only 14% and co-registration inaccuracy may have also contributed. Most patients 244 
that showed quantitative core overestimation by CTP had false positive areas in white-matter 245 
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adjacent to the lesion. Interestingly, there was no evidence that spatial and volumetric 246 
accuracy was reduced in patients with shorter imaging-to-reperfusion time. 247 
 248 
Some previous studies of CTP ischemic core segmentation accuracy have used 249 
contemporaneous diffusion MRI as the reference standard. CBF-based thresholds consistently 250 
outperformed cerebral blood volume based thresholds.26-28 However, obtaining both CT and 251 
MRI before intervention is impractical in the current era of fast endovascular workflow. There 252 
is also potential for partial reversal of diffusion lesions with rapid reperfusion,29 although 253 
reversal is uncommon when a sufficiently low apparent diffusion contrast threshold is used to 254 
define ischemic core.30 255 
 256 
We have taken an alternative approach to CTP accuracy assessment and studied follow-up 257 
diffusion lesions in patients with early reperfusion. This has practical advantages, but its 258 
accuracy depends on the modality of imaging, the time between CTP and reperfusion (in 259 
which infarct growth can continue), and the completeness of reperfusion. Voxel-based 260 
subanalysis in the MR CLEAN database using Philips CTP analysis software (Philips Medical 261 
Systems BV, Best, The Netherlands) suggested that CTP misclassified a considerable amount 262 
of the ischemic core volume compared to follow-up infarct (median 34ml).17 The different 263 
processing software and thresholds for infarction (based on cerebral blood volume) 264 
substantially differed from the processing pathway and relative CBF<30% threshold applied 265 
in RAPID. Large differences in CTP analysis results between software packages have been 266 
demonstrated previously.31,32 In addition, ischemic core volumes were considerably larger in 267 
MR CLEAN than in our study (median 49.7ml vs. 7.8ml) and the difference in results 268 
supports our finding that increased baseline ischemic core volume is associated with increased 269 
volumetric difference compared to follow-up infarct volume. RAPID has been shown to more 270 
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accurately estimate the follow-up infarct volume than other imaging packages33,34 and was 271 
used in SWIFT PRIME5, EXTEND-IA3, DAWN9 and DEFUSE310. A recent subanalysis of 272 
the SWIFT PRIME trial35 using RAPID showed good volumetric accuracy in predicting the 273 
follow-up infarct in acute stroke patients. The median baseline ischemic core volume in that 274 
study was smaller than in our population (4 (IQR 0-13)ml versus 7.8 (IQR 2-19)ml, as was 275 
the median follow-up infarct volume (18.7 (IQR 8.9-48.9)ml versus 30.8 (IQR 14.9-75.2)ml. 276 
Predictably, these smaller infarcts led to smaller volumetric inaccuracies in SWIFT PRIME 277 
(14.8 [IQR 4.9-33.7]ml) than in our study (25.4 [IQR 10.0-63.7]ml).  278 
 279 
Superficially, the spatial agreement of baseline CTP ischemic core and follow-up infarct with 280 
a Dice co-efficient of 24% appears poor. This might be partially explained by the limitations 281 
of co-registering different imaging modalities. Also, sensitivity analysis demonstrated greater 282 
inaccuracy in patients who developed HT and associated edema which also impacted the 283 
spatial agreement. However, the trend to increased volumetric difference with increasing 284 
imaging-to-reperfusion time supports a contribution of interval infarct growth. Infarct growth 285 
(which can occur despite endovascular reperfusion because of delay between imaging and 286 
reperfusion or incomplete reperfusion) lowers Dice but is unrelated to CTP core segmentation 287 
accuracy. When the potential effect of infarct growth is accounted for using the PPV, a 288 
median 68% of the baseline CTP ischemic core fell within the follow-up infarct. This should 289 
be viewed in the context of the 81% precision achieved when comparing ventricle 290 
segmentations, which provides an estimate of the best possible performance allowing for co-291 
registration inaccuracies. Both contemporaneous DWI and follow-up infarct approaches 292 
involve registration of DWI to CT, which has inherent inaccuracies due to echoplanar image 293 
distortion and differing slice thicknesses.  294 
 295 
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In this study, the estimated ischemic core volume on baseline CTP was generally smaller than 296 
the infarct volume as shown on the 24h follow-up MRI scan. This contrasts with previous 297 
studies suggesting that CTP may overestimate the final infarction, leading to concerns about 298 
unwarranted exclusion of patients from reperfusion therapies.19,36 Only 6 patients had smaller 299 
infarct volumes on 24h DWI than on baseline CTP.  300 
 301 
There are several potential reasons for larger infarct volumes at 24h than were estimated at 302 
baseline. The rCBF threshold of <30% used was specifically selected to increase specificity at 303 
the cost of sensitivity.37 A RAPID rCBF threshold of <38% improves volumetric agreement, 304 
but substantially overestimates core in some patients. Hence the 30% threshold was chosen to 305 
reduce the risk of unwarranted exclusion of patients from treatment. There was potential for 306 
interval infarct growth in the median 114 minutes between imaging and reperfusion. Notably, 307 
even the subgroup with <90min of imaging to reperfusion time generally had smaller CTP 308 
volumes compared to DWI follow-up lesion volumes. There was also potential for infarct 309 
growth in regions that remained hypoperfused as mTICI 2b only requires restoration of flow 310 
to >50% of the affected territory. However, patients with almost complete (mTICI 2c/3) 311 
reperfusion had very similar volumetric differences. Vasogenic edema also develops and, 312 
while not as pronounced at 24h as at 3-5 days, may inflate the measured infarct volume. We 313 
acknowledge that distinguishing the effect of interval infarct growth and edema from core 314 
underestimation by CTP is challenging. 315 
 316 
In visual assessment of reasons for spatial inaccuracies, almost all the patients had estimated 317 
CTP core in white-matter regions that fell outside the follow-up infarct at 24h. While these 318 
only amounted to >10ml in 14% of patients, the accurate classification of tissue viability in 319 
white-matter should be a focus of future attempts to improve the accuracy of CTP ischemic 320 
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core segmentation. The challenges of quantitatively different CBF and tolerance of ischemic 321 
insult in grey and white-matter are well known and the presence of old established ischemic 322 
damage as well as leukoaraiosis exacerbates this with further reductions in CBF.38 Robust 323 
automated grey/white segmentation on CT would be required to implement differential CBF 324 
thresholds based on tissue type into current processing pipelines, and this remains 325 
challenging. 326 
 327 
A limitation of this analysis is the potential for infarct growth beyond 24h. It is known that 328 
ischemic core continues to evolve in the days after stroke onset, although true expansion into 329 
previously unaffected territory is less likely after substantial reperfusion, as was required in 330 
this study.39 However, all time points for assessment have limitations. Later assessment at 5 331 
days, e.g. in DEFUSE240, is at the of peak of edema and overestimates the true infarct 332 
volume. At 90 days there is atrophy which underestimates the true infarct volume. Our results 333 
apply to one specific CTP rCBF threshold processed with RAPID software and would differ 334 
with other thresholds and likely with other software.31,32 Patients included in the HERMES 335 
and EXTEND-IA TNK database had relatively small ischemic core volumes at baseline, 336 
despite broad inclusion criteria in most of the contributing trials. MR CLEAN, ESCAPE, 337 
REVASCAT and EXTEND-IA TNK had no upper limit on core volume, EXTEND-IA 338 
allowed up to 70ml and SWIFT PRIME up to 50ml. The distribution of core volumes in this 339 
analysis was similar to that in DAWN and DEFUSE3 which supports the generalizability of 340 
our data. However, this analysis provides limited information on the accuracy of ischemic 341 
core volume prediction in patients with larger baseline ischemic core which may differ, based 342 
on the observed association between baseline infarct volume and volumetric discrepancy.  343 
 344 
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Conclusion 345 
CTP estimated ischemic core volumes were substantially smaller than follow-up DWI infarct 346 
lesions at 24h, particularly in patients with longer imaging to reperfusion times. Despite 347 
effective endovascular reperfusion, this may have resulted, at least in part, from infarct 348 
growth between CTP and reperfusion or subsequent infarct growth because of incomplete 349 
reperfusion or HT. This presents a methodological challenge for ischemic core validation 350 
studies. Detailed analysis revealed core overestimation predominantly in white-matter regions 351 
that should be the target of future efforts to improve CTP ischemic core accuracy. 352 
Importantly, volumetric overestimation of ischemic core by CTP was rare. Contrary to 353 
previous literature, we did not find that shorter imaging-to-reperfusion time was associated 354 
with volumetric or spatial overestimation of core volume using CTP. 355 
 356 
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Figure legends 506 
 507 
Figure 1. Scatter-plots of (a) baseline core volume and 24h follow-up infarct volume (=0.65) 508 
(b) baseline core volume and absolute volumetric difference (=0.07).  509 
 510 
Figure 2. An 89-year-old man with right M1 segment middle cerebral artery occlusion. A) 511 
Cerebral blood flow map with B) RAPID estimation of ischemic core. C) 24h diffusion MRI 512 
after successful endovascular reperfusion indicating that the basal ganglia core was correctly 513 
identified on CTP, but there was core overestimation in adjacent white-matter. D) FLAIR 514 
indicating leukoaraiosis. 515 
 516 
Figure 3. Scatter-plot of the association between imaging-to-reperfusion time and volumetric 517 
difference (calculated as 24h follow-up infarct volume – baseline infarct volume).  518 
 519 
Figure 4. Ischemic core overestimation (spatial analysis) by imaging-to-reperfusion time A) 520 
Scatter-plot. B) Boxplot for the 0-90min, 90-180min and >180min imaging-to-reperfusion 521 
time subgroups. C) Volumetric difference between baseline estimated ischemic core and 522 
follow-up infarct volume in three subgroups by imaging-to-reperfusion time. Negative 523 
volume differences on the Y-axis indicate 24h volumes higher than baseline estimated core 524 
volumes. 525 
 526 
 527 
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Tables 529 
 530 
Table 1. Patient characteristics [N=120] 531 
Mean age, yr(SD)   69.6(12.9)  
Sex, n(%) male 59(49)  
Median baseline NIHSS*(IQR) 16(14-21)  
Hypertension, n(%) 82(69)  
Atrial fibrillation, n(%)  43(36)  
Diabetes mellitus, n(%)  16(13)  
Median glucose blood level, mmol/l(IQR)  6.4(5.6-7.4)  
Smoking history, n(%)  39(35)  
Median baseline core volume, ml(IQR)  7.8(1.8-19.9)  
Median 24h follow-up infarct volume, ml(IQR)  30.8(14.9-67.6)  
Median volumetric difference, ml(IQR)  25.4(10.0-63.7)  
*National Institutes of Health Stroke Scale 532 
  533 
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Table 2. Procedural and outcome data   534 
Median onset-to-imaging time, min(IQR) [N=117] 109(71-152) 
Median imaging-to-reperfusion time, min(IQR) [N=117] 114(82-159) 
Median onset-to-reperfusion time, min(IQR) [N=117]  233(187-288) 
Median Dice similarity coefficient(IQR) [N=101] 0.24(0.15-0.37) 
Median Precision(IQR) [N=101] 0.68(0.40-0.88) 
Median Average Hausdorff Distance, mm(IQR) [N=101] 3.1(1.8-5.7) 
 535 
